Day: July 6, 2020

GREENWICH, Conn., July 06, 2020 (GLOBE NEWSWIRE) —  Bradley Jacobs, chairman and chief executive officer of XPO Logistics, Inc. (NYSE: XPO), will be the keynote speaker for the FreightWaves 2020 3PL Summit on July 21. Jacobs will lead a live, interactive town hall to launch the virtual summit “Navigating the Future of Freight.” FreightWaves is a digital content forum that provides actionable analytics on the state of the freight market, as well as global news feeds and educational events.In less than nine years, Jacobs and his management team have built XPO into a top ten global provider of transportation and logistics solutions. The company has been named to the 2020 FreightTech 25, a peer-voted list that recognizes the leading innovators in the industry.FreightWaves will host the 2020 3PL Summit in a dedicated virtual space that...

RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., July 06, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Knoxville, TN.  ADMA also announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for this second plasma collection center.“We are extremely pleased to announce the opening and commencement of operations at our second and newest ADMA BioCenters plasma collection facility,” said Adam Grossman, President and Chief Executive Officer of ADMA. “The...

Company announcement – No. 40 / 2020Zealand Pharma Expands U.S. Operations, Opens New Boston Office·Commercial operations will be headquartered in Boston, as company looks to commercialize pipeline in the U.S.Copenhagen, DK and Boston, MA, U.S. July 6, 2020 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company changing lives with innovative peptide-based medicines, today announced the opening of its new U.S. headquarters in Boston which will be led by recently appointed President of Zealand Pharma U.S., Frank Sanders.The new 5,000 square feet office, located in the Seaport at 34 Farnsworth Street, will accommodate about 40 employees who will be primarily focused on commercial and HR functions. In addition to the Seaport location, Zealand Pharma also has U.S offices in Marlborough, MA and New York, NY.“This is...

MISSISSAUGA, Ontario, July 06, 2020 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services is pleased to announce Tara Deakin as the newest appointee to its Board of Directors.Tara Deakin is a talented Human Resources executive with near 20 years of experience gained at industry leading organizations.  Today, Tara is Executive Vice-President and Chief People Officer at Spin Master Ltd., a leading global children’s entertainment company. Tara started her Human Resources career with Rogers Communications where, in her 9 years at the organization, she developed a focus on leading Training and Development functions that supported multiple lines of business which culminated in her last role as Vice President of Learning and Enablement for...

Menthol cigarettes represent US $80 billion out of the US $814 billion global tobacco market, and a 36% share of the U.S. tobacco market alone. With menthol cigarette bans passed in jurisdictions to include Brazil, Canada, and the European Union, the Company has identified unmet demand that could continue to persist as more jurisdictions follow suit. Taat Beyond Tobacco™ cigarettes are to be offered in a menthol variety, which can appeal to menthol cigarette smokers. With a near-term planned product launch on track for Q4 2020, TAAT LTD believes Taat Beyond Tobacco™ cigarettes are well-positioned to capitalize on current and emerging trends relating to menthol cigarettes.LAS VEGAS and VANCOUVER, British Columbia, July 06, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (FRANKFURT: 2TP2) (the “Company” or...

BOCA RATON, Fla., July 06, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), announced today that its subsidiary, Pollen Gear™ (“Pollen Gear”), the creator of innovative cannabis packaging solutions that promote product safety and responsible consumption in legal cannabis markets, has launched the SoftSquare Jar. Available exclusively through Greenlane, the introduction of the SoftSquare Jar expands the company’s line of proprietary ASTM/CPSC child-resistant compliant packaging products.The SoftSquare Jar is crafted from 4.5-millimeters thick glass and is available in 5 milliliters and 30 drams. The jars feature a wide mouth and rounded edges, and are designed to maintain product freshness and increase shelf life. The jar’s cap is offered in two styles—rounded square or soft square—and...

CAMBRIDGE, Mass., July 06, 2020 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) (the “Corporation”), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced the voting results from its Annual and Special Meeting of Shareholders (the “Meeting”) held on June 30, 2020.The results of the director elections were as follows:The shareholders of the Corporation also voted to reappoint Ernst & Young LLP, Chartered Professional Accountants, Licensed Public Accountants as auditors of the Corporation for the ensuing year. In addition, the disinterested shareholders approved the 2020 omnibus equity incentive plan. For complete voting results on all matters approved at the Meeting, please see the Corporation’s Report of Voting Results dated July 6, 2020 available on...

DURHAM, N.C., July 06, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that the Company will regain full rights and all data it generated for the in vivo chronic hepatitis B virus (HBV) program developed under its 2018 collaboration agreement with Gilead Sciences.“This was a highly productive and well-aligned collaboration, and we deeply value the opportunity to advance our ARCUS genome editing technology and a potential cure for HBV alongside a global leader in infectious disease,” commented Derek Jantz, Ph.D., Chief Scientific Officer, Precision BioSciences. “Key learnings from this program and how to develop liver-directed gene editing therapeutic candidates are...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, July 06, 2020 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, announced today that it filed a final short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities regulatory authorities in each of the provinces of Canada, except Québec, (the “Securities Regulators”) on July 3, 2020 (the “Effective Date“).The Base Shelf Prospectus allows Spectral to qualify the distribution by way of a prospectus of up to $50 million of common shares, debt securities, subscription receipts, warrants and units, or any combination thereof, from time to time, during the 25-month period from...

Company Now Caught Up in Financial ReportingFirst Quarter Net Sales of $61.7 millionMARIETTA, Ga., July 06, 2020 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the filing of its 2020 first quarter Form 10-Q. The Company has additionally filed each of the 2019 Form 10-Qs, for the first, second, and third quarters of 2019, and is now caught up in its financial reporting.Peter M. Carlson, MiMedx Chief Financial Officer, said, “This is a significant milestone for MiMedx. We have made tremendous progress as a company with the filing of our 2019 Annual Report, the closing of critical financing from premier healthcare investors, and the addition of two industry leaders to our Board of Directors....